Dae Ryong Cha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dae Ryong Cha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dae Ryong Cha Today - Breaking & Trending Today

Aptabio to present results of Isuzinaxib Phase 2 study at The American Society of Nephrology (ASN)'s Kidney Week 2022

Published: November 4, 2022

Aptabio's Isuzinaxib (APX-115) proves its effect on a key kidney function marker in a Phase 2 clinical study in patients with diabetes and chronic kidney...

Source: prnewswire.com

Related Topics:

United StatesSouth KoreaPrnewswire AptabioHyesung ShinDae Ryong ChaCenters For DiseaseKorea University College Of MedicineHuman ServicesDrug Development CompanyPlatform TechnologyAptabio Therapeutics IncAmerican Society Of NephrologyUs Department Of HealthUrine Albumin Creatine RatioIsuzinaxib PhaseAmerican SocietyKidney WeekHigh Impact Clinical TrialsPatients With TypeDouble BlindPlacebo Controlled PhaseKidney DiseaseKidney InjuryKorea University CollegeAptabio Therapeutics